New drug IBI3032 tested in healthy people for first time
Knowledge-focused
Recruiting now
This Phase 1 trial is testing the safety and tolerability of a single dose of IBI3032 in 32 healthy adults. Participants are randomly assigned to receive either the drug or a placebo. The study is for research only and is not meant to treat any medical condition.
Phase: PHASE1 • Sponsor: Fortvita Biologics (USA)Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:42 UTC